ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila

BSE368.155.75 (+1.59 %)

PREV CLOSE ( ) 362.40

OPEN PRICE ( ) 365.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 92243

TODAY'S LOW / HIGH ( )360.15 373.55

52 WK LOW / HIGH ( )319.4 668.85

NSE368.105.6 (+1.54 %)

PREV CLOSE( ) 362.50

OPEN PRICE ( ) 364.50

BID PRICE (QTY) 368.10 (2559)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3218921

TODAY'S LOW / HIGH( ) 360.25 373.65

52 WK LOW / HIGH ( )319 668.9

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995

Management Info

Pankaj R Patel - Chairman Sharvil P Patel - Managing Director

Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103-20/71800000

Email investor.grievance@zyduscadila.com/dhavalsoni@zyduscadila.com

Website www.zyduscadila.com

Registrars Details

Link Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE, MCX

NEWS

23May Zydus Lifesciences zooms despite repor
Zydus Lifesciences is currently trading at Rs. 365.60, up by 8.45 points..

20May Zydus Lifesciences reports 41% fall in
Zydus Lifesciences has reported results for fourth quarter and year ende..

16May Zydus Lifesciences informs about post
Zydus Lifesciences has informed that the financial results of the compan..

13May Zydus Lifesciences launches Bemdac to
Zydus Lifesciences has launched Bemdac (Bempedoic acid), a new class of..

13May Zydus Lifesciences informs about press
Zydus Lifesciences has informed that it enclosed a copy of press release..

Financials

in Millions

	QTR Mar 22	ANNUAL 22
Net Profit	2469	8579
Gross Profit	3465	11639
Operating Profit	5113	20968
Net Sales	20193	79819

EVENT CALENDAR

peer group

Abbott India (BSE) 18191.80 (2.47%)	M.Cap ( in Cr)38656.31
Dr. Reddy's Lab (BSE) 4351.10 (1.80%)	M.Cap ( in Cr)72413.55
Shilpa Medicare (BSE) 453.25 (10.47%)	M.Cap ( in Cr)3934.30
Hikal (BSE) 391.75 (6.69%)	M.Cap ( in Cr)4830.31
Kwality Pharma (BSE) 417.10 (5.00%)	M.Cap ( in Cr)432.79

	NON-INSTITUTION	9.69%
	PROMOTERS	74.88%
	FI/BANKS/INSURANCE	7.23%
	MUTUAL FUNDS/UTI	5.55%
	GOVERNMENT	0.08%
	FII	0%

Scheme Name	Hold(%)
UTI Healthcare Fund...	2.84
ICICI Pru Retiremen...	2.18
ICICI Pru Child Car...	2.05
Baroda BNP Paribas ...	2.04
ICICI Pru Exports &...	2.02
Nippon India Nifty ...	1.99

About Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd. was incorporated in the year 1995. Its today's share price is 368.15. Its current market capitalisation stands at Rs 37689.08 Cr. In the latest quarter, company has reported Gross Sales of Rs. 77904 Cr and Total Income of Rs.78706 Cr. The company's management includes Dhaval N Soni, Apurva S Diwanji, Dharmishta N Raval, Nitin R Desai, Bhadresh K Shah, Mukesh M Patel, Ganesh N Nayak, Sharvil P Patel, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of ZYDUSLIFE and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote